Page last updated: 2024-11-05

vantocil

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

polihexanide: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID20977
CHEMBL ID2106939
SCHEMBL ID45011
SCHEMBL ID20753163
MeSH IDM0059732

Synonyms (20)

Synonym
28757-47-3
1-(diaminomethylidene)-2-hexylguanidine
polihexanide hydrochloride
polihexanide
lavasept
vantocil
CHEMBL2106939
cosmocil cq
purista
microcare mbg
AKOS017531707
SCHEMBL45011
n-hexylbiguanide
n-hexylimidodicarbonimidic diamide
24717-31-5
DTXSID40873856
Q408205
FT-0700841
VAZJLPXFVQHDFB-UHFFFAOYSA-N
SCHEMBL20753163

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"To evaluate the cysticidal effect of polyhexamethylene biguanide (PHMB) and chlorhexidine on Acanthamoeba and its toxic effect on cultured human keratocytes."( Cysticidal effect on acanthamoeba and toxicity on human keratocytes by polyhexamethylene biguanide and chlorhexidine.
Choi, HY; Lee, JE; Lee, JS; Oum, BS; Yu, HS, 2007
)
0.34
" However, PHMB seemed to be more toxic to keratocytes than chlorhexidine."( Cysticidal effect on acanthamoeba and toxicity on human keratocytes by polyhexamethylene biguanide and chlorhexidine.
Choi, HY; Lee, JE; Lee, JS; Oum, BS; Yu, HS, 2007
)
0.34
"These new findings suggest that most of multipurpose solutions are toxic with oxidative stress and apoptosis induction."( Cytotoxicity of contact lens multipurpose solutions: role of oxidative stress, mitochondrial activity and P2X7 cell death receptor activation.
Baudouin, C; Dutot, M; Rat, P; Warnet, JM, 2008
)
0.35
" Any adverse event of the treatment has been monitored throughout the study."( The efficacy and safety of a single dose of polyhexamethylene biguanide gynaecologic solution versus a seven-dose regimen of vaginal clindamycin cream in patients with bacterial vaginosis.
Di Renzo, GC; Ferrari, A; Gerli, S; Minozzi, M; Papaleo, E,
)
0.13
" However, little is known about their potential toxic properties."( [A comparative in vitro study of cell toxicity of clinically used antiseptics].
Goertz, O; Hirsch, T; Jacobsen, F; Niederbichler, A; Rittig, A; Seipp, HM; Steinau, HU; Steinstraesser, L, 2009
)
0.35
"Lavasept showed only slight to moderate toxic effects on cellular vitality and proliferation."( [A comparative in vitro study of cell toxicity of clinically used antiseptics].
Goertz, O; Hirsch, T; Jacobsen, F; Niederbichler, A; Rittig, A; Seipp, HM; Steinau, HU; Steinstraesser, L, 2009
)
0.35
" Furthermore, antimicrobial efficacy and toxic properties must be included in the clinical decision process for optimal therapy of chronic wounds."( [A comparative in vitro study of cell toxicity of clinically used antiseptics].
Goertz, O; Hirsch, T; Jacobsen, F; Niederbichler, A; Rittig, A; Seipp, HM; Steinau, HU; Steinstraesser, L, 2009
)
0.35
" Our hypothesis was that antiseptics and supplemental irrigation with sodium chloride lavage are less toxic on human chondrocytes than treatment with antiseptics only."( Toxicity of antiseptics against chondrocytes: what is best for the cartilage in septic joint surgery?
Arnholdt, J; Kolar, P; Matziolis, G; Perka, C; Röhner, E; Seeger, JB; Thiele, K, 2011
)
0.37
" Polyhexanide possibly has more toxic potential than hydrogen peroxide against human chondrocytes after an application >15 minutes."( Toxicity of polyhexanide and hydrogen peroxide on human chondrocytes in vitro.
Dähn-Wollenberg, S; Hoff, P; Matziolis, G; Perka, C; Röhner, E; Seeger, JB, 2011
)
0.37
" The superficially adhering PHMB film produces no adverse effects on MG63 cells within a 48 h-cell culture, but promotes the initial attachment and spreading of the osteoblasts on the modified Ti6Al4V surface within 15 min."( Poly (hexamethylene biguanide) adsorption on hydrogen peroxide treated Ti-Al-V alloys and effects on wettability, antimicrobial efficacy, and cytotoxicity.
Benkhai, H; Finke, B; Friedrichs, W; Geist, N; Kramer, A; Langel, W; Matthes, R; Müller, G, 2014
)
0.4
" For the in vitro cytotoxic test with L929 mouse fibroblast cells, our novel dressing was not toxic to the cells and also promoted cell migration as good as the commercially available dressing, possibly due to the component of sericin released."( The safety and efficacy of bacterial nanocellulose wound dressing incorporating sericin and polyhexamethylene biguanide: in vitro, in vivo and clinical studies.
Aramwit, P; Napavichayanun, S; Yamdech, R, 2016
)
0.43
" Few adverse effects from the substance were reported."( Polyhexanide - safety and efficacy as an antiseptic.
Fjeld, H; Lingaas, E, 2016
)
0.43
" The discovery and establishment of safe and effective alternative antiseptics are important issues for the treatment of infected wounds."( Comparing two polymeric biguanides: chemical distinction, antiseptic efficacy and cytotoxicity of polyaminopropyl biguanide and polyhexamethylene biguanide.
Böhm, JK; Fromm-Dornieden, C; Rembe, JD; Schäfer, N; Stuermer, EK, 2016
)
0.43
" No sign of infection or adverse event was observed after treatment with both dressings."( Inflammatory reaction, clinical efficacy, and safety of bacterial cellulose wound dressing containing silk sericin and polyhexamethylene biguanide for wound treatment.
Ampawong, S; Angspatt, A; Aramwit, P; Harnsilpong, T; Napavichayanun, S, 2018
)
0.48
" Adverse events, tolerability and vital signs were assessed before, during, after and at the end of the treatment period."( Tolerability and safety of urotainer® polihexanide 0.02% in catheterized patients: a prospective cohort study.
Everaert, K; Kesselring, J; Möhr, S; Pannek, J; Van der Aa, F; Vance, W, 2020
)
0.56
"There was no serious adverse event in the study."( Tolerability and safety of urotainer® polihexanide 0.02% in catheterized patients: a prospective cohort study.
Everaert, K; Kesselring, J; Möhr, S; Pannek, J; Van der Aa, F; Vance, W, 2020
)
0.56
" The Panel reviewed relevant data relating to the safety of this ingredient and concluded that Polyaminopropyl Biguanide is safe in cosmetics in the present practices of use and concentration described in the safety assessment, when formulated to be nonirritating and nonsensitizing, which may be based on a quantitative risk assessment or other accepted methodologies."( Safety Assessment of Polyaminopropyl Biguanide (Polyhexamethylene Biguanide Hydrochloride) as Used in Cosmetics.
Belsito, DV; Bergfeld, WF; Boyer, I; Heldreth, B; Hill, RA; Johnson, W; Klaassen, CD; Liebler, DC; Marks, JG; Shank, RC; Slaga, TJ; Snyder, PW; Zhu, J,
)
0.13
" The rates of dose-limiting adverse events (DLAEs) leading to interruption of dosing, mild adverse events (AEs) (not dose limiting) and incidental AEs (unrelated to treatment) were compared."( Safety and tolerability of topical polyhexamethylene biguanide: a randomised clinical trial in healthy adult volunteers.
Asero, N; Dart, JKG; Minassian, DC; Overweel, J; Papa, V; Rottey, S; Sallet, G; van der Meulen, I, 2022
)
0.72
" Secondary outcomes included: central line-associated infection; primary bloodstream infection; local infection; skin complications; device/dressing dwell time; serious adverse events, and cost-effectiveness."( Polyhexamethylene biguanide discs versus unmedicated dressings for prevention of central venous catheter-associated infection in the intensive care unit: A pilot randomised controlled trial to assess protocol safety and feasibility.
Corley, A; Irvine, L; Larsen, E; Marsh, N; McGuinness, N; Pearse, I; Pelecanos, A; Rapchuk, IL; Rickard, CM; Ullman, AJ; Ziegenfuss, M, 2022
)
0.72
"Polyhexamethylene biguanide discs appear safe for central venous catheter infection prevention."( Polyhexamethylene biguanide discs versus unmedicated dressings for prevention of central venous catheter-associated infection in the intensive care unit: A pilot randomised controlled trial to assess protocol safety and feasibility.
Corley, A; Irvine, L; Larsen, E; Marsh, N; McGuinness, N; Pearse, I; Pelecanos, A; Rapchuk, IL; Rickard, CM; Ullman, AJ; Ziegenfuss, M, 2022
)
0.72
" AK treatment is prolonged and requires multiple drugs, which can lead to adverse effects."( Comparing cytotoxicity and efficacy of miltefosine and standard antimicrobial agents against Acanthamoeba trophozoites and cyst forms: An in vitro study.
Kazemirad, E; Latifi, A; Mohebali, M; Rezaian, M; Soleimani, M; Yasami, S, 2023
)
0.91

Compound-Compound Interactions

ExcerptReferenceRelevance
"From July 1996 to March 1997, three cases of Acanthamoeba keratitis combined with fungal infection were diagnosed and treated at our ophthalmic department."( Treatment of Acanthamoeba keratitis combined with fungal infection with polyhexamethylene biguanide.
Sheu, MM; Tien, SH, 1999
)
0.3
" Polyhexanide was tested alone and in combination with oxacillin, penicillin G, ampicillin, cefazolin, cefuroxime, imipenem, gentamicin, erythromycin, doxycycline, levoflocaxin, linezolid and vancomycin."( In-vitro activity of polyhexanide alone and in combination with antibiotics against Staphylococcus aureus.
Fabry, W; Kock, HJ, 2014
)
0.4
" aureus alone and in combination with antibiotics."( In-vitro activity of polyhexanide alone and in combination with antibiotics against Staphylococcus aureus.
Fabry, W; Kock, HJ, 2014
)
0.4
" This study is designed to assess the effect of antimicrobial-impregnated dressing (AMD) combined with negative-pressure wound therapy (NPWT) on skin graft survival."( Antimicrobial-impregnated dressing combined with negative-pressure wound therapy increases split-thickness skin graft engraftment: a simple effective technique.
Chen, CC; Chew, KY; Kuo, YR; Wu, CC, 2015
)
0.42
" Cultured human corneal epithelial (HCE) cells and Acanthamoeba were treated with polyhexamethylene biguanide (PHMB) combined with cellulose synthesis inhibitors to evaluate the CPE as an antiamebic agent."( Potential Value of Cellulose Synthesis Inhibitors Combined With PHMB in the Treatment of Acanthamoeba Keratitis.
Chung, DI; Goo, YK; Hong, Y; Kong, HH; Moon, EK, 2015
)
0.42

Dosage Studied

ExcerptRelevanceReference
"The exposure of human osteoblasts and endothelial cells to polyhexanide at concentrations with questionable antibacterial activity resulted in severe cell damage whereas exposure to high dosed gentamicin did not."( Effect of polyhexanide and gentamycin on human osteoblasts and endothelial cells.
Eulert, J; Hendrich, C; Ince, A; Jakob, F; Löhr, JF; Schütze, N, 2007
)
0.34
" In addition, the Sphingomonads were the only isolates capable of growth in axenic cultures dosed with PHMB."( Microbial degradation of the biocide polyhexamethylene biguanide: isolation and characterization of enrichment consortia and determination of degradation by measurement of stable isotope incorporation into DNA.
Collins, AN; O'Malley, LP; Shaw, CH, 2007
)
0.34
"Timely identification of the pathogen, with repeated culture and smear if necessary, as well as adequate dosage to prevent recurrence is highly recommended in order to preclude the need for therapeutic penetrating keratoplasty."( Medical treatment for combined Fusarium and Acanthamoeba keratitis.
Hsiao, CH; Huang, SC; Lin, HC; Lin, MY; Ma, DH; Tan, HY; Yeh, LK, 2009
)
0.35
" The MTT assay showed significant dose-response decreases of 500 nm absorbance for all MPS-treated cells."( Cytotoxicity and effects on metabolism of contact lens care solutions on human corneal epithelium cells.
Boost, MV; Cho, P; Choy, CK, 2012
)
0.38
" The increasing incidence of hemangiosarcomas highly probably resulted from increased endothelial proliferation, triggered by the exceedingly high dosage fed, because PHMB is not genotoxic and there is no evidence for epigenetic effects."( Re-evaluation of polihexanide use in wound antisepsis in order to clarify ambiguities of two animal studies.
Assadian, O; Dissemond, J; Eberlein, T; Kramer, A; Müller, G, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (503)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (1.59)18.7374
1990's47 (9.34)18.2507
2000's112 (22.27)29.6817
2010's250 (49.70)24.3611
2020's86 (17.10)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 33.82

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index33.82 (24.57)
Research Supply Index6.40 (2.92)
Research Growth Index5.45 (4.65)
Search Engine Demand Index46.79 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (33.82)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials71 (13.42%)5.53%
Reviews34 (6.43%)6.00%
Case Studies79 (14.93%)4.05%
Observational3 (0.57%)0.25%
Other342 (64.65%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]